EMA approves two sites for production of Pfizer's COVID-19 vaccine
One site, located in Monza, Italy, is operated by Patheon Italia S.p.A. The other in Anagni, also in Italy, is operated by Catalent Anagni S.R.L. Both sites will manufacture finished product. These sites will produce up to 85 million additional doses to supply the EU in 2021.
These recommendations do not require a European Commission decision and the sites can become operational. ■